2.0ml Autoclavable Self-Standing Sterile Cryogenic Vials Universal Screw Threads Clear 81-7204

Name: 2.0ml Autoclavable Self-Standing Sterile Cryogenic Vials Universal Screw Threads Clear 81-7204
Brand: Biologix Corporation
SKU: 1920862832

Shandong, ChinaBiologix Corporation

US$0.01-0.08

2,000 Pieces

Product profile

Customization

Available

Disposable

Certification

CE, ISO, FDA

Model NO.

81-7204

Material

PP Material

Sterile

Gamma Radiation

Temperature

-86c~121c

Other

Dnase, Rnase Free

Transport Package

50 Sets/Pack, 40 Packs/Case

Trademark

BIOLOGIX

Origin

Changzhou City, Jiangsu Province, China

Company profile

Biologix Corporation

Shandong, China

Business Type: Manufacturer/FactoryExport Year: 2022-05-09Nearest Port: ShanghaiAverage Response Time: ≤4.73hTerms of Payment: LC, T/T, PayPal, etc.International Commercial Terms(Incoterms): FOB, EXW, CIF, Others, CFR, FCA, DDP, DAP, CIP, CPT

AI-Powered supplier vetting

SummaryBiologix Corporation, based in Jinan, Shandong, China, is a limited liability manufacturer specializing in laboratory consumables and instruments. It holds ISO 9001 and GMP certifications, indicating robust quality management. The company emphasizes R&D, expanding its product offerings to meet scientific and healthcare needs. With a global presence and multiple export markets, it operates over 10 production lines and has an annual output exceeding US$100 million. The company began exporting in 2022 and accepts various payment terms, including LC, PayPal, and T/T.

Supplier typeThe supplier is a manufacturing factory known as Biologix Corporation, located in China and specializes in health, medicine, and chemical products.

CertificationsBiologix Corporation holds ISO 9001 and GMP certifications, demonstrating a commitment to quality management and manufacturing standards.

R&D capabilityBiologix Corporation invests continuously in R&D to expand its product portfolio, indicating a strong focus on innovation.

Production capacityThe supplier operates more than 10 production lines with an annual output exceeding US$100 million, showcasing significant production capacity.